MONTREAL, QUEBEC -- (MARKET WIRE) -- October 03, 2006 -- ART Advanced Research Technologies Inc. (“ART”) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that Mr. Sebastien Gignac, the Company’s newly appointed President & CEO, will present ART’s recent developments in achieving key milestones at the BioContact Quebec 2006 investor conference, to be held at the Fairmount Chateau Frontenac in Quebec City (Canada) from October 4 to 6. Mr. Gignac is scheduled to present on Wednesday, October 4, 2006, at 3:00 p.m. (EST) in the Jacques-Cartier Room.
